Trial · NCT00617461
Results by group113
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 113
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Change From Baseline in the Mean 24-hour Average Pain Intensity (API) Score at the Last Week of Each Treatment Period Using Last Observation Carried Forward (LOCF) Data | GEn 1200 mg | -1.18 | Standard Error 0.171 | points on a scale | |
| Change From Baseline in the Mean 24-hour Average Pain Intensity (API) Score at the Last Week of Each Treatment Period Using Last Observation Carried Forward (LOCF) Data | GEn 3600 mg | -1.47 | Standard Error 0.173 | points on a scale | |
| Change From Baseline in the Mean 24-hour Average Pain Intensity (API) Score at the Last Week of Each Treatment Period Using LOCF Data for Each Treatment Period | GEn 1200 mg in First Intervention Period | -1.11 | Standard Deviation 1.477 | points on a scale | |
| Change From Baseline in the Mean 24-hour Average Pain Intensity (API) Score at the Last Week of Each Treatment Period Using LOCF Data for Each Treatment Period | GEn 3600 mg in First Intervention Period | -1.09 | Standard Deviation 1.366 | points on a scale | |
| Change From Baseline in the Mean 24-hour Average Pain Intensity (API) Score at the Last Week of Each Treatment Period Using LOCF Data for Each Treatment Period | GEn 1200 mg in Second Intervention Period | -1.29 | Standard Deviation 1.742 | points on a scale | |
| Change From Baseline in the Mean 24-hour Average Pain Intensity (API) Score at the Last Week of Each Treatment Period Using LOCF Data for Each Treatment Period | GEn 3600 mg in Second Interevention Period | -1.92 | Standard Deviation 2.000 | points on a scale | |
| Change From Baseline in the Mean Day-time Average Pain Intensity (API) Score at the Last Week of Each Treatment Period Using LOCF Data | GEn 1200 mg | -1.17 | Standard Error 0.172 | points on a scale | |
| Change From Baseline in the Mean Day-time Average Pain Intensity (API) Score at the Last Week of Each Treatment Period Using LOCF Data | GEn 3600 mg | -1.48 | Standard Error 0.174 | points on a scale | |
| Change From Baseline in the Mean Day-time Worst Pain Intensity Score at the Last Week of Each Treatment Period Using LOCF Data | GEn 1200 mg | -1.17 | Standard Error 0.178 | points on a scale | |
| Change From Baseline in the Mean Day-time Worst Pain Intensity Score at the Last Week of Each Treatment Period Using LOCF Data | GEn 3600 mg | -1.50 | Standard Error 0.181 | points on a scale | |
| Change From Baseline in the Mean Current (Evening) Pain Intensity Score at the Last Week of Each Treatment Period Using LOCF Data | GEn 1200 mg | -1.10 | Standard Error 0.180 | points on a scale | |
| Change From Baseline in the Mean Current (Evening) Pain Intensity Score at the Last Week of Each Treatment Period Using LOCF Data | GEn 3600 mg | -1.39 | Standard Error 0.183 | points on a scale | |
| Change From Baseline in the Mean Night-time Average Pain Intensity (API) Score at the Last Week of Each Treatment Period Using LOCF | GEn 1200 mg | -0.92 | Standard Error 0.188 | points on a scale | |
| Change From Baseline in the Mean Night-time Average Pain Intensity (API) Score at the Last Week of Each Treatment Period Using LOCF | GEn 3600 mg | -1.21 | Standard Error 0.190 | points on a scale | |
| Change From Baseline in the Mean Night-time Worst Pain Intensity Score at the Last Week of Each Treatment Period Using LOCF | GEn 1200 mg | -0.97 | Standard Error 0.192 | points on a scale | |
| Change From Baseline in the Mean Night-time Worst Pain Intensity Score at the Last Week of Each Treatment Period Using LOCF | GEn 3600 mg | -1.33 | Standard Error 0.194 | points on a scale | |
| Change From Baseline in the Mean Current Morning Pain Intensity Score at the Last Week of Each Treatment Period Using LOCF | GEn 1200 mg | -1.11 | Standard Error 0.187 | points on a scale | |
| Change From Baseline in the Mean Current Morning Pain Intensity Score at the Last Week of Each Treatment Period Using LOCF | GEn 3600 mg | -1.46 | Standard Error 0.189 | points on a scale | |
| Number of Participants Achieving Various Levels of Percent Reduction From Baseline in the Mean 24-hour Average Pain Intensity Score at the Last Week of Each Treatment Period Using LOCF Data | GEn 1200 mg | 0% or more | 68 | participants | |
| Number of Participants Achieving Various Levels of Percent Reduction From Baseline in the Mean 24-hour Average Pain Intensity Score at the Last Week of Each Treatment Period Using LOCF Data | GEn 3600 mg | 0% or more | 71 | participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00617461/results